These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9790107

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
    Pilloni L, Bianco P, Difelice E, Cabras S, Castellanos ME, Atzori L, Ferreli C, Mulas P, Nemolato S, Faa G.
    Eur J Histochem; 2011 Jun 07; 55(2):e20. PubMed ID: 22193299
    [Abstract] [Full Text] [Related]

  • 4. Pathology of tumor-stroma interaction in melanoma metastatic to the skin.
    Smolle J, Woltsche I, Hofmann-Wellenhof R, Haas J, Kerl H.
    Hum Pathol; 1995 Aug 07; 26(8):856-61. PubMed ID: 7635447
    [Abstract] [Full Text] [Related]

  • 5. Quantitative morphology of collagen fibers in cutaneous malignant melanoma and melanocytic nevus.
    Smolle J, Fiebiger M, Hofmann-Wellenhof R, Kerl H.
    Am J Dermatopathol; 1996 Aug 07; 18(4):358-63. PubMed ID: 8879298
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Actin-binding protein expression in benign and malignant melanocytic proliferations.
    Bouffard D, Duncan LM, Howard CA, Mihm MC, Byers HR.
    Hum Pathol; 1994 Jul 07; 25(7):709-14. PubMed ID: 8026830
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 15. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
    Singh RS, Diwan AH, Zhang PS, Prieto VG.
    J Cutan Pathol; 2007 Mar 15; 34(3):220-5. PubMed ID: 17302605
    [Abstract] [Full Text] [Related]

  • 16. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.
    Wessel C, Westhoff CC, Nowak K, Moll I, Barth PJ.
    Virchows Arch; 2008 Nov 15; 453(5):485-9. PubMed ID: 18813945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
    Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU, Garin-Chesa P.
    J Invest Dermatol; 2003 Feb 15; 120(2):182-8. PubMed ID: 12542520
    [Abstract] [Full Text] [Related]

  • 19. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
    Sagebiel RW.
    J Invest Dermatol; 1993 Mar 15; 100(3):322S-325S. PubMed ID: 8440914
    [Abstract] [Full Text] [Related]

  • 20. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May 15; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.